My research focuses on pharmacokinetics in HIV studies, with a particular emphasis on the PK profiling of subcutaneously administered broadly neutralizing antibodies. My interests include investigating determinants of pharmacokinetic variability, as well as exploring biomarkers linked to antibody exposure, immune function, and therapeutic response to support precision approaches in HIV treatment and prevention.
I aspire to be a researcher specializing in pharmacokinetics and infectious disease therapeutics, with a focus on antibody-based treatments, biomarker discovery, and optimizing precision medicine approaches to improve outcomes in HIV and related diseases.